José Luis
Izquierdo Alonso
Profesor/a Titular Universidad
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von GlaxoSmithKline (United Kingdom) (4)
2024
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422
2022
-
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
International journal of chronic obstructive pulmonary disease, Vol. 17, pp. 3097-3109
2021
-
Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain
Journal of Medical Economics, Vol. 24, Núm. 1, pp. 874-882
2020
-
Cost-effectiveness analysis of a once-daily single-inhaler triple therapy for patients with chronic obstructive pulmonary disease (COPD) using the fulfil trial: A Spanish perspective
International Journal of COPD, Vol. 15, pp. 1621-1632